![Gary Jay Sternberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gary Jay Sternberg
Fondateur chez
Stargazer Pharmaceuticals, Inc.
Profil
Gary Jay Sternberg is the founder of Stargazer Pharmaceuticals, Inc. Current jobs include Chief Executive Officer at RainBio, Inc. since 2021.
Former jobs include Chief Executive Officer at Tisbury Pharmaceuticals, Inc., Director-Sales at Fovea Pharmaceuticals SA from 2006 to 2009, Group Medical Director & Head-Medical Affairs at GeneTech, Inc., Chief Business Officer at Sesen Bio, Inc. from 2014 to 2016, and Chief Medical Officer at Aerie Pharmaceuticals, Inc. from 2022 to 2023.
Education includes an MBA from The University of Chicago and a doctorate from The State University of New York.
Postes actifs de Gary Jay Sternberg
| Sociétés | Poste | Début |
|---|---|---|
Stargazer Pharmaceuticals, Inc.
 Stargazer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical drugs | Fondateur | - |
RainBio, Inc.
 RainBio, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapy for corneal treatments | Directeur Général | 12/10/2021 |
Anciens postes connus de Gary Jay Sternberg
| Sociétés | Poste | Fin |
|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/02/2023 |
| CARISMA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/11/2016 |
GeneTech, Inc.
 GeneTech, Inc. Medical/Nursing ServicesHealth Services Provides fetal DNA testing and clinical services | Directeur Technique/Scientifique/R&D | - |
Tisbury Pharmaceuticals, Inc.
 Tisbury Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical-stage pharmaceutical company that discovers, develops and manufactures pharmaceutical drugs to treat primary open angle glaucoma | Directeur Général | - |
Fovea Pharmaceuticals SA
 Fovea Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs for the treatment of ocular diseases | Corporate Officer/Principal | - |
Formation de Gary Jay Sternberg
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
50
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that discovers, develops and commercializes ophthalmic therapies for the treatment of patients with eye diseases | Health Technology |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The State University of New York
 The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fovea Pharmaceuticals SA
Fovea Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs for the treatment of ocular diseases | Health Technology |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics to treat eye diseases | Health Technology |
GeneTech, Inc.
GeneTech, Inc. Medical/Nursing ServicesHealth Services Provides fetal DNA testing and clinical services | Health Services |
Tisbury Pharmaceuticals, Inc.
Tisbury Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical-stage pharmaceutical company that discovers, develops and manufactures pharmaceutical drugs to treat primary open angle glaucoma | Commercial Services |
Stargazer Pharmaceuticals, Inc.
Stargazer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical drugs | Health Technology |
RainBio, Inc.
RainBio, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapy for corneal treatments | Health Technology |
